BioWednesday Webinar: The Bioavailability Toolbox

Registration is now closed. Please contact Alicia@onenucleus.com to be added to the waitlist.

In collaboration with Catalent.

One Nucleus in collaboration with Catalent will host a BioWednesday providing insights into how to classify new therapeutic drug candidates and identify issues relating to oral product development.

To anticipate and address challenges, Catalent experts will provide an overview of tools available and how coupling different technologies could improve issues with API form and bioavailability of poorly soluble compounds.  This will include insights into early modelling, preformulation and formulation tools and to plan for success in preclinical and early-stage clinical studies, including how to shift to an integrated drug development ecosystem.

Programme
16:00 - Welcome from One Nucleus
Alicia Gailliez, One Nucleus
16:05 - Maximising the Bioavailability Toolbox for Poorly Soluble Oral Drugs to Drive Greater Long-term Success 
Stephen Tindal, Director, Science & Technology, Catalent Pharma Solutions
Jan Neelissen, Scientific Advisor, Catalent Pharma Solutions
16:45 - Q&A
17:00 - Close

Prices
One Nucleus Members: Free
Non-Members: £50 +VAT
Academics: please contact Alicia